GREAT POINT PARTNERS LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$153.8B
Holdings
26
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ISIIONIS PHARMACEUTICALS INC | 500,000 | $19.8B | 12.84% | |
| 2 | RZLTREZOLUTE INC | 3,033,462 | $13.5B | 8.80% | |
| 3 | AMLXAMYLYX PHARMACEUTICALS INC | 2,000,000 | $12.8B | 8.34% | |
| 4 | LEGNLEGEND BIOTECH CORP | 350,000 | $12.4B | 8.08% | |
| 5 | ABVXABIVAX SA | 1,291,617 | $9.9B | 6.42% | |
| 6 | NGNENEUROGENE INC | 485,859 | $7.3B | 4.72% | |
| 7 | AKBAAKEBIA THERAPEUTICS INC | 1,985,915 | $7.2B | 4.70% | |
| 8 | EOLSEVOLUS INC | 720,118 | $6.6B | 4.31% | |
| 9 | ACLXARCELLX INC | 100,000 | $6.6B | 4.28% | |
| 10 | XENEXENON PHARMACEUTICALS INC | 200,000 | $6.3B | 4.07% | |
| 11 | AKROAKERO THERAPEUTICS INC | 103,848 | $5.5B | 3.60% | |
| 12 | JBIOJADE BIOSCIENCES INC | 498,054 | $5.0B | 3.24% | |
| 13 | CYTKCYTOKINETICS INC | 150,000 | $5.0B | 3.22% | |
| 14 | IMVTIMMUNOVANT INC | 262,176 | $4.2B | 2.73% | |
| 15 | UNCYUNICYCIVE THERAPEUTICS INC | 796,558 | $3.8B | 2.47% | |
| 16 | KALVKALVISTA PHARMACEUTICALS INC | 323,170 | $3.7B | 2.38% | |
| 17 | TSHATAYSHA GENE THERAPIES INC | 1,500,000 | $3.5B | 2.25% | |
| 18 | DBVTDBV TECHNOLOGIES S A | 374,679 | $3.4B | 2.23% | |
| 19 | ZURAZURA BIO LTD | 3,170,194 | $3.3B | 2.16% | |
| 20 | UPBUPSTREAM BIO INC | 300,000 | $3.3B | 2.14% | |
| 21 | CNTXCONTEXT THERAPEUTICS INC | 4,683,711 | $3.1B | 2.00% | |
| 22 | CNTACENTESSA PHARMACEUTICALS PLC | 225,000 | $3.0B | 1.92% | |
| 23 | SRRKSCHOLAR ROCK HLDG CORP | 61,607 | $2.2B | 1.42% | |
| 24 | PMNEURPROMIS NEUROSCIENCES INC | 2,645,128 | $1.3B | 0.83% | |
| 25 | PLRXPLIANT THERAPEUTICS INC | 850,000 | $986.0M | 0.64% | |
| 26 | HLXCHELIX ACQUISITION CORP II | 29,381 | $312.0M | 0.20% |